Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05761223 |
| Title | A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | 1ST Biotherapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mary Crowley Cancer Research Center | RECRUITING | Dallas | Texas | 40118 | United States | Details |
| NEXT Oncology San Antonio | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Next Oncology Virginia | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Summit Cancer Centers - Spokane Valley | RECRUITING | Spokane | Washington | 99208 | United States | Details |